World Wealth Journal
SEE OTHER BRANDS

Bringing you the latest news on finance and banking

World Wealth Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wealth Journal.

Press releases published on August 4, 2025

Castle Biosciences Reports Second Quarter 2025 Results

Castle Biosciences Reports Second Quarter 2025 Results

Delivered Q2 2025 revenue of $86 million Q2 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 33% over Q2 2024 Raising full-year 2025 revenue guidance range to $310-320 million from $287-297 million …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President …

Denny’s Corporation Reports Results for Second Quarter 2025

Denny’s Corporation Reports Results for Second Quarter 2025

SPARTANBURG, S.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Denny’s Corporation (the "Company") (NASDAQ: DENN), owner and operator of Denny's Inc. ("Denny's") and Keke's Inc. ("Keke's") today reported results for its second quarter ended June 25, 2025 and …

Armada Hoffler Reports Second Quarter 2025 Results

Armada Hoffler Reports Second Quarter 2025 Results

GAAP Net Income of $0.04 Per Diluted Share for the Second Quarter Normalized FFO of $0.25 Per Diluted Share for the Second Quarter Same Store NOI Growth of 1.4% (GAAP) Positive Office Releasing Spreads of 11.7% (GAAP) and 5.5% (Cash) Positive Retail …

iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference

iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference

NASHVILLE, Tenn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 11, 2025. iMDx will host a live …

HEO and Satellogic Expand Agreement with Exclusive Access to Non-Earth Imagery for Space Domain Awareness

HEO and Satellogic Expand Agreement with Exclusive Access to Non-Earth Imagery for Space Domain Awareness

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL), a leader in satellite manufacturing and high-resolution Earth observation data, today announced an expanded agreement with HEO, the world’s leading commercial provider of non- …

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Nasdaq Reports July 2025 Volumes

Nasdaq Reports July 2025 Volumes

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for July 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. …

Open Lending Announces Early Extension of AmTrust Producer Agreement

Open Lending Announces Early Extension of AmTrust Producer Agreement

AUSTIN, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or the “Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced …

CVG Reports Second Quarter 2025 Results

CVG Reports Second Quarter 2025 Results

Second quarter sales of $172 million, EPS of $(0.12), Adjusted EBITDA of $5.2 million Continued strong free cash flow generation Updates full year 2025 guidance NEW ALBANY, Ohio, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVG (NASDAQ: CVGI), a diversified …

Navitas Semiconductor Announces Second Quarter 2025 Financial Results

Navitas Semiconductor Announces Second Quarter 2025 Financial Results

Delivered revenue of $14.5 million Announcing increased focus on AI data centers and energy infrastructure built on strategic partnerships with ecosystem leaders, $100 million capital raise, and a new lower-cost manufacturing partner TORRANCE, Calif., Aug. …

Letter to Stockholders Issued by Diamondback Energy, Inc

Letter to Stockholders Issued by Diamondback Energy, Inc

MIDLAND, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Diamondback Stockholders, This letter is meant to be a supplement to our earnings release and is being furnished to the Securities and Exchange Commission (SEC) and released to our stockholders …

Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook

Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with …

Diamondback Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results

Diamondback Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results

MIDLAND, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced financial and operating results for the second quarter ended June 30, 2025. SECOND QUARTER 2025 AND RECENT HIGHLIGHTS …

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Second Quarter 2025 Financial and Operating Results

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Second Quarter 2025 Financial and Operating Results

MIDLAND, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Viper Energy, Inc., (NASDAQ:VNOM) (“Viper” or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback”), today announced financial and operating results for the second quarter …

Currenc Group Inc. Announces Second Quarter and First Half 2025 Financial Results

Currenc Group Inc. Announces Second Quarter and First Half 2025 Financial Results

SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Currenc Group Inc. (Nasdaq: CURR) (“Currenc” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced its financial results …

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million …

Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions